Significance of E-Cadherin and p16 Advanced Endometrial Cancer: A Gynecologic Oncology Group Phase II Study

被引：0
|
作者：
Singh, M.
Darcy, K. M.
Brady, W. E.
Weber, Z.
Akalin, A.
Whitney, C. W.
Zaino, R.
Ramirez, N.
Leslie, K. K.
机构：
[1] SUNY Stony Brook, Stony Brook, NY 11794 USA
[2] New York State Dept Hlth, Roswell Pk Mem Inst, Gynecol Oncol Grp, Buffalo, NY 14263 USA
[3] Univ Colorado Denver, Aurora, CO USA
[4] Univ Massachusetts, Worcester, MA 01605 USA
[5] Christiana Gynecol Grp, Newark, DE USA
[6] Hershey Med Ctr, Hershey, PA USA
[7] Nationwide Childrens Hosp, Columbus, OH USA
[8] Univ Iowa, Iowa City, IA USA
来源：
LABORATORY INVESTIGATION | 2010年 / 90卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1180
引用
收藏
页码：263A / 264A
页数：2
相关论文
共 50 条
  • [1] Significance of E-Cadherin and p16 Advanced Endometrial Cancer: A Gynecologic Oncology Group Phase II Study
    Singh, M.
    Darcy, K. M.
    Brady, W. E.
    Weber, Z.
    Akalin, A.
    Whitney, C. W.
    Zaino, R.
    Ramirez, N.
    Leslie, K. K.
    MODERN PATHOLOGY, 2010, 23 : 263A - 264A
  • [2] Methylation of p16 and E-cadherin in ameloblastoma
    Park, Chan-Woong
    Yoon, Hye-Kyoung
    Park, Sang-Jun
    JOURNAL OF THE KOREAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS, 2010, 36 (06) : 453 - 459
  • [3] Phase II trial of danazol in advanced, recurrent, or persistent endometrial cancer: a Gynecologic Oncology Group study
    Covens, A
    Brunetto, VL
    Markman, M
    Orr, JW
    Lentz, SS
    Benda, J
    GYNECOLOGIC ONCOLOGY, 2003, 89 (03) : 470 - 474
  • [4] A phase II trial of amonafide in patients with endometrial cancer - A gynecologic oncology group study
    Asbury, R
    Blessing, JA
    Reid, GC
    McGuire, WP
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1998, 21 (04): : 406 - 407
  • [5] Hypermethylation of P15, P16, and E-cadherin genes in ovarian cancer
    Moselhy, Said S.
    Kumosani, Taha A.
    Kamal, I. H.
    Jalal, J. A.
    Jabaar, Hassan S. Abdul
    Dalol, Ashraf
    TOXICOLOGY AND INDUSTRIAL HEALTH, 2015, 31 (10) : 924 - 930
  • [6] Phase II Trial of Bevacizumab in Recurrent or Persistent Endometrial Cancer: A Gynecologic Oncology Group Study
    Aghajanian, Carol
    Sill, Michael W.
    Darcy, Kathleen M.
    Greer, Benjamin
    McMeekin, D. Scott
    Rose, Peter G.
    Rotmensch, Jacob
    Barnes, Mack N.
    Hanjani, Parviz
    Leslie, Kimberly K.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (16) : 2259 - 2265
  • [7] Preoperative chemoradiation for advanced vulvar cancer: A phase II study of the gynecologic oncology group
    Moore, DH
    Thomas, GM
    Montana, GS
    Saxer, A
    Gallup, DG
    Olt, G
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 42 (01): : 79 - 85
  • [8] A phase II trial of anastrozole in advanced recurrent or persistent endometrial carcinoma: A gynecologic oncology group study
    Rose, PG
    Brunetto, VL
    VanLe, L
    Bell, J
    Walker, JL
    Lee, RB
    GYNECOLOGIC ONCOLOGY, 2000, 78 (02) : 212 - 216
  • [9] Phase II study of medroxyprogesterone acetate plus tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study
    Whitney, CW
    Brunetto, VL
    Zaino, RJ
    Lentz, SS
    Sorosky, J
    Armstrong, DK
    Lee, RB
    GYNECOLOGIC ONCOLOGY, 2004, 92 (01) : 4 - 9
  • [10] Prognostic Significance of E-Cadherin Protein Expression in Endometrial Cancer
    Vasilakaki, Th
    Tsavari, A.
    Skafida, E.
    Koulia, K.
    Moustou, E.
    Arkoumani, E.
    Myoteri, D.
    Manoloudaki, K.
    SCIENTIFIC CHRONICLES, 2012, 17 (02) : 83 - 86
12345